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Objective: To evaluate the involvement of community pharmacists in primary health care; 
determine extent of the pharmacists’ participation in curative and preventive services, as well 
as partially assess quality of the involvement. 
Methods: A 27-item self-completion questionnaire with 0.92 reliability was administered to 
110 community pharmacists in Benin City, Nigeria.  Data were collected on a scale that 
ranged from 27 to 135 with an assumed neutral point of 81 and statistically analysed. 
Results: Respondents scored 87.92 ± 31.31, and over half (55%) were above the neutral 
point.  This implies a slightly satisfactory but not significant involvement (p = 0.25447). Mean 
total rating on curative services was 92.61±29.6, p = 0.0759 with 58% above the neutral point. 
Infectious diseases accounted for majority of the interventions. Involvement in preventive 
services was very poor. Only 31% scored above the neutral point with a rating of 
65.61±31.05, p = 0.2377. Quality of involvement was 94.77±36.18 which was not significant 
(p = 0.2866). Majority of the respondents (94%) claimed they would be prepared to participate 
in further training on primary health care programme.   
Conclusion: Community pharmacists are marginally involved in the primary health care 
programmes in Benin City and are willing to improve on their performance. Continuing 
education on primary health care and incorporation of primary health care role of community 
pharmacists in the curriculum of pharmacy schools might be helpful. 
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Introduction 
 
All health systems contain four essential 
levels of care: lay self-care, primary 
professional care, general specialist care 
and super specialist care1.  Within this 
structure, primary health care (PHC) is the 
first level of professional contact in the 
community and this forms the corner-stone 
strategy for the attainment of level of health 
that will permit socially and economically 
productive life.  Since 1978, member states 
of the World Health Organisation (WHO) 
have accepted primary health care as their 
health policy. Some crucial roles 
recommended for community pharmacists in 
the PHC programmes include the following2-
4: 
 
• Advise government on a regular basis on 
the selection of the drugs most 
appropriate for the programmes; 
• Form a network for the storage and 
distribution of essential vaccines to 
enhance coverage; 
• Promote the sale and distribution of 
essential drugs; 
• Train and supervise community health 
workers on the proper handling, usage 
and administration of essential drugs; 
• Provide expanded/clinical pharmaceutical 
services with proper documentation; 
• Promote health through public health 
education and enlightenment program-
mes; and 
• Be involved in training and retraining of 
community health workers. 
 
In a survey that was undertaken to 
document the Primary Health Care role of 
pharmacists in London, the volume of 
primary contacts, the types of problems 
handled and the advice given by the 
pharmacists were of particular interest5. The 
contribution of pharmacists in primary care 
was found to be large, with neighbourhood 
pharmacies being the most active.  Eighty 
per cent of all problems were handled by 
recommending over-the-counter drugs. The 
pharmacist appears to be comfortable in this 
function, although a conflict may exist 
between his professional and merchant 
roles5. Hamley et al 6 studied integrating 
clinical pharmacists into the Primary Health 
Care team: a framework for rational and cost 
effective prescribing.  In the study, a change 
to generic name prescription was achieved 
without patient complaints and the overall 
generic prescribing level increased from 57 
to 68%. Generic substitution was therefore a 
primary health care role to save cost. Using 
a cross - sectional survey, Flobbe et al7 
evaluated pharmacy - based screening 
programmes in South Africa. Overall, 57% of 
the pharmacies provided at least one 
screening test. Blood pressure measure-
ment, serum cholesterol, capillary glucose 
and pregnancy testing were the most 
commonly offered services. Screening tests 
were conducted less than five times a week, 
except for blood pressure measurement that 
was more frequent. Only 35% of pharmacies 
kept records. No quality control procedures 
were used and pharmacists’ knowledge 
about the tests such as false positive and 
false negative results was poor8. The 
pharmacy profession was pursuing an 
extended role for pharmacists in primary 
health care. An independent enquiry into 
pharmacy practice has concluded that 
pharmacists are underused resource. A 
wide-ranging development of their roles was 
therefore recommended9. The Scottish Audit 
Commission report has also recommended 
the integration of clinical pharmacists into 
the PHC team as a framework for rational 
and cost effective prescribing6. In South 
Africa, pharmacists and nurses have been 
reported to have a team approach towards 
PHC and such partnership was found to be 
mutually beneficial in expanding their 
professional activities with substantial 
benefits in the process. These include 
potential increases in profit, enlarging the 
clientele base and improving the image of 
the pharmacy, by shifting the focus from a 
place of disease to a place of health, as well 
as creating the vision of the pharmacist as a 
team member in providing PHC10. 
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Smith et al11 used generalisability theory to 
assess the quality of primary health care.  In 
the study, a random sample of pharmacists 
from all London postal districts was selected 
and visited for set periods throughout one 
year.  Encounters between clients and 
pharmacists were tape – recorded.  
Performance regarding disease 
prevention/health promotion activity was 
poorest. Thus, the quality of most 
consultations was found to be either very 
good or very poor, relatively few occupying 
middle ground.  
 
Nigerian community pharmacists perform 
PHC roles without official acknowledgement.  
A survey of their involvement in the 
programmes of PHC in Lagos showed that 
they have not been adequately integrated 
into these programmes12. In Lagos, Nigeria, 
Eniojukan and Adeniyi12 found the overall 
involvement of community pharmacists to be 
approximately 41% of the programme items 
they studied; with supply of essential drugs 
and vaccines, oral rehydration therapy, and 
family planning topping the list. The training 
of health personnel in PHC and screening 
for common diseases were the poorest12.  
However, no study on the involvement of 
community pharmacists in PHC programmes 
in Benin City has so far been reported. We 
consider such a study important. Such 
research finding(s) will be beneficial in the 
cost effective delivery of pharmaceutical 
services at community level. Policy makers 
may find it useful in developing and 
formulating appropriate policies to ensure 
effective utilization of the untapped potential 
of the community pharmacist. Trainers of 
pharmaceutical manpower may also benefit 
if the research identifies gaps in the 
knowledge of pharmacists. Furthermore, the 
community pharmacists may want to know 
how well they are performing the functions 
the society expects of them, since the 
society is the major determinant of what 
functions it can entrust a professional group 
with, based on its perceptions of the 
profession. 
This study was therefore necessary to 
document the involvement of community 
pharmacists in PHC in Benin City, Nigeria.  
The following research questions therefore 
arise: What are the extent and quality of 
community pharmacists’ involvement in 
PHC? The main objective of the study was 
to quantitatively evaluate community 
pharmacists’ involvement in PHC in Benin 
City, Nigeria. The specific objectives were to 
determine the involvement of community 
pharmacists in curative services, to 
determine the involvement of community 
pharmacists in preventive health care 
services, and to assess the quality of the 







This investigation was carried out from June 
to September 1999 in Benin City, Edo State, 
Nigeria.  The city is a state capital with a 
projected population of 1.2 million 
inhabitants made up of different socio-
economic strata. Health care facilities in the 
city include two tertiary facilities namely a 
university teaching hospital and a psychiatric 
hospital along with two secondary health 
care facilities – a military hospital and a state 
owned general hospital.  There are also over 
fifty private hospitals and clinics, several 
patent medicine shops and traditional 
medicine clinics. The City had 110 
community pharmacists and 89 registered 
community pharmacies, some of which had 
more than one pharmacist as at the time of 
the study. The location of the pharmacies 
tends to emphasize the commercial interests 
of the pharmacists in the City with about 
50% of the pharmacies located within the 
vicinity of the government hospitals while the 
remaining are scattered in no definite pattern 
over the rest of the City. Patients pay for all 
their medicines and supplies as the 
proposed National Health Insurance Scheme 
is yet to be implemented.  
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Sample 
 
All the 110 community pharmacists in Benin 
City (at the time of this study)were included 
in the study. A self-completion questionnaire 
was administered to the pharmacists in their 
premises. Completed questionnaire copies 
were retrieved on follow-up visit after one to 
two weeks. Non-responders were followed 
up with oral interview to explore their 
opinions, and reasons given for their non- 
participation ranged from lack of time to lack 




A 27-item stem consisting of 5 points 
response scale was developed for the 
survey questionnaire.  Items included in the 
instrument covered different aspects of PHC 
programmes such as: awareness, basic 
enabling structure, curative services, 
preventive services, procedures, participa-
tion in training programmes, and adequacy 
of professional training.  Respondents were 
requested to rate their opinions on the scale 
of 1 – 5 (lowest to highest) provided. The 
instrument was pre-faced: very frequent = 5, 
frequent = 4, not sure = 3, less frequent = 2, 
and not at all = 1. Since all the items were in 
one direction, a summation of the scores 
was assessed to reflect the level of 
performance; high score correlating with 
high level of involvement and vice versa. 
 
Validity and reliability of the instrument 
 
Selecting items suggested by professional 
literature and expert opinions validated 
(content or face validity) the instrument. The 
questionnaire was pre-tested on a sample of 
20 community pharmacists who the purpose 
of the study was explained to. The result of 
the pilot study was correlated with the 
sample response using Spearman’s rank 
difference method. This procedure has been 
employed in our previous investigation13. 
Since the pre-testing did not result in major 
modification of the instrument, the results 
were included in the final study. 
 
Analysis of data 
 
The retrieved usable copies of the 
questionnaire were entered on Microsoft 
Excel computer package for sorting and 
analysed with Instat version 2.05a 
(Graphpad Inc., USA). On the 5-point scale, 
“5” represented the highest mean score 
while “1” represented the lowest mean 
score.  And on the 27-item scale the lowest 
possible score would be 27 while the highest 
possible score would be 135. A logical 
neutral point was assumed to be 81 i.e. 
midpoint between 27 and 135. Since the 
summated score correlated with level of 
involvement of community pharmacists in 
PHC, scores above 81 were taken as 
positive. The standard deviation was 
calculated as a measure of item variability 
from the mean score.  Any low standard 
deviation indicated cluster of responses to 
the mean while high standard deviation 
reflected high variability of opinions from the 
mean. The percentage performance was the 
number of respondents that scored above 
the critical or neutral point on the rating 




The survey questionnaire response rate was 
90.9% and this was considered to be 
reasonably high. The reliability of the 
instrument was found to be 0.92 using 
Spearman’s rank correlation method. The 
results of the general participation of the 
community pharmacists in PHC programmes 
are shown in Table 1. Each item deals with 
an aspect of PHC and the more the number 
of items, the higher the reliability of the 
measurement. The pharmacists scored 
87.92 ± 31.31 which is above the critical 
point of 81 and this suggests a slightly 
satisfactory or marginal involvement. More 
than half (55%) of the respondents scored 
above the critical point.  
 
Using 7-item measures (Table 1), the 
respondents scored 65.61 ± 31.05 on 
preventive services, and this falls far below 
the critical point of 81 on the rating scale.  
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This is considered very poor (p = 0.2377).  
Less than one-third of the respondents 
(31%) were involved in preventive services.   
The involvement of the pharmacists in 
curative health care services is given in 
Table 2. The mean total score of 92.61 ± 
29.16 appears moderately satisfactory.  
More than half (58%) of the respondents are 
involved in curative services. The most 
prevalent diseases which the pharmacists 
are frequently involved in the treatment are 
as follows: malaria (100%), cough (95%), 
UTI/STD (78%), typhoid fever (69%), sore 
throat (69%), helminthiasis (64%), diarrhoea 
(63%) and peptic ulcer disease (60%). 
 
Table 3 identifies 9 items that can partially 
measure quality of care.  Sixty per cent of 
the respondents scored above 94.77 ± 
36.18. A comparison of performance of the 
respondents in curative and preventive 





In a similar work conducted in Lagos Nigeria, 
the pharmacists scored an average of 41% 
actual involvement on a 10-item scale12. In 
this study, however, there is a sharp contrast 
between level of awareness (90%) and the 
level of involvement (55%); also 83% 
reported to have BP apparatus while only 
35% were said to screen for hypertension. 
This disparity may be explained by the high 
percentage (94%) of pharmacists who 
believed they would need further training on 
PHC programmes. Community pharmacists’ 
Table 1: Item analysis of responses for general participation in PHC programmes 
 




Level of awareness of PHC 
Community pharmacists as providers 
Preparedness for new PHC roles 
Blood pressure apparatus 
Thermometer 
Bathroom scale 
Dressing Kit/First aid box 
Adequacy of training 
Preparedness for further training 
Treatment of common diseases and injuries 
Screening for hypertension 
Screening for drug interactions 
Detection of adverse drug reactions 
Generic substitution 
Health promotion and disease prevention 
Use of family planning devices 
Physical examination 
Ordering of routine lab tests 
Body mass index (obesity) 
Vaccination against tetanus 
Vaccination against rabies 
Referral of patients 
Diarrhoea management with ORS 
Syndromic management of STDs 
Supply of essential drugs and dressings 
Patient medication counseling 
Participation in training programmes on PHC 
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involvement in screening patients can 
contribute to the early detection of those at 
risk of coronary heart diseases who need 
immediate referral.  
 
The importance pharmacists attach to vital 
health promotion behaviours and their health 
promotion beliefs have been shown to affect 
their practices14. Also, community pharma-
cists performance regarding disease 
prevention/health promotion activity has 
been reported to be poor in a study carried 
out in London11. This result is similar to our 
findings despite the disparity in the level of 
development of Nigeria and England. 
 
Quality of care is best evaluated using all the 
three quality measures (structure, process 
and outcome)15. It has been postulated that 
outcomes are probably weakly related to 
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quality of the care process16. In many 
instances process can indirectly predict 
outcome e.g. syndromic management of 
STDs and use of ORS in diarrhoea will likely 
yield favourable outcomes. The present 
study, which employed multiple structural 
and process items, can therefore relatively 
measure the quality of care. The study has 
identified a high level of involvement of 
community pharmacists in treatment of 
prevalent diseases. This may raise some 
legal/ethical questions as to functions of the 
pharmacist in health care delivery. In 
Nigeria, the existing pharmacy laws are yet 
to incorporate this aspect of pharmacy 
practice. However, WHO Revised Drug 
Strategy Resolution WHA 47.12 recognizes 
the key role of pharmacists in public health 
and the use of medicines. It emphasizes 
their responsibility to provide informed 
objective advice on medicines and their use, 
to promote the concept of pharmaceutical 
care, and actively participate in illness 
prevention and health promotion17.  
 
Community pharmacies are very frequently 
the first contact with the health care system, 
often before a General Practitioner18. There 
is a high frequency of contacts with low 
barriers to access to health care: no 
appointments, no long waiting time, 
convenient opening hours, and they are 
located within the community. Regular 
contacts offer access to a wide range of 
people, namely, healthy persons, those 
showing symptoms, patients undergoing 
treatment, relatives and other care givers; 
people from all social strata.18 It would be 
necessary to pursue relevant policies to 
enhance the utilization of the untapped 
potentials of community pharmacists, 
especially as primary health care is the 





There is slightly satisfactory involvement of 
the community pharmacists in PHC services 
in Benin City as more than half (55%) of the 
pharmacists scored about 87.92 on the 
rating scale.  The quality of care was fair.  
 
Continuing education programmes with 
emphasis on health promotion and disease 
prevention is recommended. Additionally, 
inclusion of primary health care course work 
and experiential activities as part of the 
curriculum in pharmacy schools is 
imperative. Also the legal framework of 
community pharmacists’ involvement in PHC 
should be concretized.  In South Africa, 19 
when a pharmacist supplies medicine to a 
patient resulting from a specific response to 
symptoms or after thorough questions and 
examination of a patient, certain ethical and 
legal provisions govern his acts. While 
section 36(1) of the Medical, Dental and 
Supplementary Health Professionals Act 
1974 makes it unlawful for persons other 
than registered medical professionals from 
examining a patient for a gain, sub-section 
36(2) exempts a pharmacist registered 
under Pharmacy Act No. 53 of 1974. This 
makes pharmacists’ initiated therapy an 
integral part of professional practice in PHC 
in South Africa.  This is an example for 
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